definiens: means the date first given above ; 1.5 1.1.5 shall mean [COMPANY] or RGI as the context requires and shall mean both [COMPANY] and RGI ; 1.6 and words importing persons shall be construed as to include individuals, firms, bodies corporate, joint ventures . governments, states or agencies of state or any undertaking ( whether or not having separate legal personality and irrespective of the jurisdiction in or under the laws of which it was incorporated or exists ) ; 1.7 shall mean the provision of the Services pursuant to this Agreement and the evaluati(:m by the Parties of whether to add other projects and services to this Agreement ; 3 CONFIDENTIAL TREATMENT REQUESTED 1 .8 shall mean employees and sub - contractors Involved in providing the Services and named in the relevant Schedule or otherwise agreed to in writing by [COMPANY] ; 1.9 means the services to be provided by RGI pursuant to this Agreement ( as amended from time to time in accordance with the provisions of this Agreement ) and such other services as may from time to time be agreed upon by RGI and [COMPANY], including Testing Services, consultation and tissue storage, in connection with this Agreement and as further detailed and agreed upon in a SOW pursuant to Article 1 below ; 1.10 '' Term '' means that this Agreement shall commence on the Effective Date and shall continue until the third ( 3rd)anniversary of the Effective Date ( ), unless sooner terminated in accordance with the provisions hereof, renewable at the option of, and upon the agreement of both Parties in additional one ( 1 ) year increments ( ), ; and 1.11 '' Testing Services " means RGl 's business, among other things, of conducting molecular - based tumor tissue profiling using a proprietary and patented process developed by RGI which involves a complex molecular analysis of specific molecular markers that provides valuable tumor specific gene expression information obtained from a paraffin preserved fresh or frozen tissue sample, which can help the physician choose the most appropriate therapy for a patient prior to starting treatment or assist a pharmaceutical company in identifying the appropriate candidate patient population suitable for a therapy in development